Oligodendrogliomas are characterized by IDH1/2 mutations in combination with complete 1p/19q codeletion, often with TERT promoter mutations and CIC/FUBP1 alterations, which results in a favorable prognosis and chemosensitivity [14]. Here, IDH1 is linked to oligodendroglioma.